ScholarIQanswers from OpenAlex & ORCID
Zhen Wang
ResearcherPublications, citations & collaboration network
Zhen Wang is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Zhen Wang have?
ScholarIQindexed works
Zhen Wang has 925 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Zhen Wang have?
ScholarIQcitation count
Zhen Wang has 20,237 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Zhen Wang?
ScholarIQh-index
Zhen Wang has an h-index of 69 in OpenAlex.
What is the i10-index of Zhen Wang?
ScholarIQi10-index
Zhen Wang has an i10-index of 383 in OpenAlex.
What is the ORCID of Zhen Wang?
ScholarIQorcid
The ORCID for Zhen Wang is on the source record.
What is the OpenAlex record for Zhen Wang?
ScholarIQopenalex
The OpenAlex for Zhen Wang is on the source record.
What are the most-cited papers on Zhen Wang?
ScholarIQmost cited works
γδT17 Cells Promote the Accumulation and Expansion of Myeloid-Derived Suppressor Cells in Human Colorectal Cancer
Pin Wu, Dang Wu, Chao Ni, Jun Ye, Wuzhen Chen, Guoming Hu, Zhen Wang, Changrong Wang, Zhigang Zhang, Wenjie Xia, Zhigang Chen, Ke Wang, Tao Zhang, Jinghong Xu, Yuehua Han, Ting Zhang, Xianguo Wu, Jianwei Wang, Weihua Gong, Shu Zheng, Fuming Qiu, Jun Yan, Jian Huang
The natural history of untreated severe or critical limb ischemia
Abd Moain Abu Dabrh, Mark W. Steffen, Chaitanya Undavalli, Noor Asi, Zhen Wang, Mohamed B. Elamin, Michael S. Conte, M. Hassan Murad
Lung Adenocarcinoma Harboring EGFR T790M and In Trans C797S Responds to Combination Therapy of First- and Third-Generation EGFR TKIs and Shifts Allelic Configuration at Resistance
Zhen Wang, Jin‐Ji Yang, Jie Huang, Junyi Ye, Xu‐Chao Zhang, Hai‐Yan Tu, Han Han‐Zhang, Yi‐Long Wu
A comprehensive review of uncommon EGFR mutations in patients with non-small cell lung cancer
Hai‐Yan Tu, E‐E Ke, Jin‐Ji Yang, Yue‐Li Sun, Hong‐Hong Yan, Ming-Ying Zheng, Xiaoyan Bai, Zhen Wang, Jian Su, Zhihong Chen, Xu‐Chao Zhang, Zhong‐Yi Dong, Si-Pei Wu, Ben‐Yuan Jiang, Hua‐Jun Chen, Bin-Chao Wang, Chong‐Rui Xu, Qing Zhou, Ping Mei, Donglan Luo, Wen‐Zhao Zhong, Xue‐Ning Yang, Yi‐Long Wu
Ivonescimab Plus Chemotherapy in Non–Small Cell Lung Cancer With <i>EGFR</i> Variant
HARMONi-A Study Investigators, Wen‐Feng Fang, Yuanyuan Zhao, Yongzhong Luo, Runxiang Yang, Yan Huang, Zhiyong He, Hui Zhao, Mingjun Li, Kai Li, Qibin Song, Xiaobo Du, Yulan Sun, Wei Li, Fei Xu, Zhiyu Wang, Kunning Yang, Yun Fan, Baogang Liu, Hongyun Zhao, Ying Hu, Lee Jia, Xu Shen, Tienan Yi, Dongqing Lv, Haitao Lan, Mengxia Li, Wenhua Liang, Yongsheng Wang, Hui Yang, Yuming Jia, Yuan Chen, Jun‐Guo Lu, Jifeng Feng, Chunling Liu, Ming Zhou, Jianya Zhou, Xianling Liu, Ningning Zhou, Ming He, Xiaorong Dong, Hualin Chen, Yongxing Chen, Haichuan Su, Xiaoling Li, Zhihong Zhang, Lei Yang, Ying Cheng, Likun Chen, Xue Hou, Yu Zhang, Jun Guo, Zhen Wang, Hong Lu, Di Wu, Weineng Feng, Wen Li, Jian‐An Huang, Yan Wang, Xia Song, Jiewen Peng, Laiyu Liu, Yubiao Guo, Wenting Li, Dongmei Lu, Mingxiu Hu, Zhongmin Maxwell Wang, Baiyong Li, Michelle Xia, Li Zhang